高级检索
当前位置: 首页 > 详情页

Association between LXR-alpha and ABCA1 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus in a Chinese Han Population

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing, China [2]Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China [3]Beijing Key Lab for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Science, China- Japan Friendship Hospital, Beijing, China
出处:
ISSN:

摘要:
We designed a case-control study and selected LXR-alpha rs7120118 C>T and ABCA1 rs2230806 A>G polymorphisms to determine the correlation between these polymorphisms and diabetic kidney disease (DKD) susceptibility in a Chinese Han population. Three hundred DKD patients and 346 type 2 diabetes mellitus (DM) patients without kidney disease were recruited. Our results showed that rs7120118 was associated with DKD (genotype, P=.027; allele, P<.011). rs7120118 was associated with a higher risk of DKD under a dominant model adjustment by age and sex (P=.015) and an additive model (P=.040); rs2230806 was associated with a higher risk of DKD under an recessive model (P<.03); the combined effect of rs7120118 CC+rs2230806 GG genotype showed an association of DKD adjustment for age and sex (P=.009). In subgroup analysis of patients without hypercholesterolemia, the rs2230806 genotype frequencies were different between the two groups (P=.042). rs2230806 was associated with increased risk of DKD under a recessive model adjustment for age and sex (P=.013) and an additive model (P=.031). Our results suggest that LXR-alpha rs7120118 is significantly associated with a higher risk of DKD, and ABCA1 rs2230806 is significantly associated with a higher risk of DKD without hypercholesterolemia in Chinese Han individuals.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 4 区 内分泌学与代谢
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢 3 区 医学:研究与实验
JCR分区:
出版当年[2018]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q3 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2018版] 出版当年五年平均[2014-2018] 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)